A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding

计划入组 200,000 人 · 首次发布于 2006 年 12 月 22 日

A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

计划入组 6,400 人 · 首次发布于 2006 年 4 月 24 日

MPS (RaDiCo Cohort) (RaDiCo-MPS)

计划入组 1,000 人 · 首次发布于 2023 年 9 月 14 日

tavilermide hydrochloride

AAV gene therapy (MPS IIIA)

AAV gene therapy (MPS IIIB)

Abeona Therapeutics

United States

BIG LOTS

India

DOJS HOLDINGS PTY LTD

Australia

Scientific Industries Launches DOTS MPS for Cell Culture Biopharma Market, Reports 24% Bioprocessing Revenue Growth

Denali Therapeutics Plans Accelerated Approval Filing for Tividenofusp Alfa in MPS II

Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A